New culturally tailored program aims to boost overdose prevention in black communities

NCT ID NCT06609278

Completed Knowledge-focused Sponsor: Brittany Miller-Roenigk Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tested a harm reduction program designed specifically for Black adults who misuse opioids or stimulants. 63 participants completed surveys before and after the program to see if their knowledge, confidence, and willingness to use overdose prevention techniques improved. The program also offered free fentanyl test strips, naloxone (Narcan), and first aid supplies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: harm reduction educational intervention
What this could lead to: If successful, this approach could help reduce overdose deaths and improve safety among Black adults who misuse opioids or stimulants.
What could go wrong: This is a small, completed study with no control group, so results may not apply broadly. The intervention's long-term impact is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Harm Reduction opiate dependence Opiate Overdose opioid abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE STIMULANT USE

Contacts and locations

Locations

Louisville Central Community Center

Louisville, Kentucky, 40203, United States
University of Cincinnati

Cincinnati, Ohio, 45221, United States
Urban Minority Alcoholism and Drug Abuse Outreach Program (UMADAOP) of Cincinnati

Cincinnati, Ohio, 45219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.